| Diabetes fact sheets in Korea, 2018: an appraisal of current status E Han, NH Cho, MK Kim, HS Kim, Y Wang, WP Koh, MK Jensen, JM Yuan, ... Diabetes & metabolism journal 43 (4), 487-494, 2019 | 136 | 2019 |
| The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in Daegu, South Korea MK Kim, JH Jeon, SW Kim, JS Moon, NH Cho, E Han, JH You, JY Lee, ... Diabetes & metabolism journal 44 (4), 602-613, 2020 | 115 | 2020 |
| Association between dietary acid load and the risk of cardiovascular disease: nationwide surveys (KNHANES 2008–2011) E Han, G Kim, N Hong, Y Lee, DW Kim, HJ Shin, BW Lee, ES Kang, ... Cardiovascular diabetology 15 (1), 1-14, 2016 | 92 | 2016 |
| Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases E Han, Y Lee Diabetes & metabolism journal 41 (6), 430-437, 2017 | 78 | 2017 |
| Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk E Han, Y Lee, YD Kim, BK Kim, JY Park, SH Ahn, BW Lee, ES Kang, ... Official journal of the American College of Gastroenterology| ACG 115 (4 …, 2020 | 75 | 2020 |
| Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia E Han, Y Yun, G Kim, Y Lee, HJ Wang, BW Lee, BS Cha, BS Kim, ... PLoS One 11 (5), e0154683, 2016 | 68 | 2016 |
| Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study G Kim, SY Jang, E Han, Y Lee, S Park, CM Nam, ES Kang International journal of cancer 140 (4), 798-806, 2017 | 64 | 2017 |
| Ipragliflozin additively ameliorates non-alcoholic fatty liver disease in patients with type 2 diabetes controlled with metformin and pioglitazone: a 24-week randomized … E Han, Y Lee, BW Lee, ES Kang, BS Cha Journal of clinical medicine 9 (1), 259, 2020 | 63 | 2020 |
| Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008–2011 E Han, Y Lee, G Kim, SR Kim, BW Lee, ES Kang, CW Ahn, BS Cha Metabolism 65 (10), 1531-1540, 2016 | 61 | 2016 |
| Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease Y Kim, E Han, JS Lee, HW Lee, BK Kim, MK Kim, HS Kim, JY Park, ... Gut and Liver 16 (2), 290, 2022 | 58 | 2022 |
| Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: Nationwide population-based cohort study SH Ko, YM Park, JS Yun, SA Cha, EK Choi, K Han, E Han, Y Lee, YB Ahn Journal of Diabetes and its Complications 32 (2), 157-163, 2018 | 50 | 2018 |
| Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B E Han, Y Lee, BK Kim, JY Park, DY Kim, SH Ahn, BW Lee, ES Kang, ... Alimentary pharmacology & therapeutics 48 (3), 300-312, 2018 | 44 | 2018 |
| A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes E Han, HS Park, O Kwon, EY Choe, HJ Wang, Y Lee, SH Lee, CH Kim, ... Medicine 95 (44), 2016 | 44 | 2016 |
| Rosiglitazone use and the risk of bladder cancer in patients with type 2 diabetes E Han, SY Jang, G Kim, Y Lee, EY Choe, CM Nam, ES Kang Medicine 95 (6), 2016 | 41 | 2016 |
| Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008–2011) E Han, Y Lee, BW Lee, ES Kang, IK Lee, BS Cha Cardiovascular diabetology 16 (1), 1-11, 2017 | 40 | 2017 |
| Visceral adiposity is associated with altered myocardial glucose uptake measured by 18 FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes G Kim, K Jo, KJ Kim, Y Lee, E Han, H Yoon, HJ Wang, ES Kang, M Yun Cardiovascular diabetology 14 (1), 1-10, 2015 | 40 | 2015 |
| Risk of incident dementia according to metabolic health and obesity status in late life: a population-based cohort study JY Lee, K Han, E Han, G Kim, H Cho, KJ Kim, BW Lee, ES Kang, BS Cha, ... The Journal of Clinical Endocrinology & Metabolism 104 (7), 2942-2952, 2019 | 39 | 2019 |
| 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association JH Choi, KA Lee, JH Moon, S Chon, DJ Kim, HJ Kim, NH Kim, JA Seo, ... Diabetes & Metabolism Journal 47 (5), 575-594, 2023 | 30 | 2023 |
| Combining SGLT2 inhibition with a thiazolidinedione additively attenuate the very early phase of diabetic nephropathy progression in type 2 diabetes mellitus E Han, E Shin, G Kim, JY Lee, Y Lee, BW Lee, ES Kang, BS Cha Frontiers in endocrinology 9, 412, 2018 | 30 | 2018 |
| Risk assessment and management of post-transplant diabetes mellitus E Han, MS Kim, YS Kim, ES Kang Metabolism 65 (10), 1559-1569, 2016 | 26 | 2016 |
